Noncoding RNAs as circulating biomarkers in osteosarcoma patients-Reference-Cited by-同舟云学术

Noncoding RNAs as circulating biomarkers in osteosarcoma patients

Published:2019-04-29 Issue:11 Volume:234 Page:19249-19255
ISSN:0021-9541
Container-title:Journal of Cellular Physiology
language:en
Short-container-title:J Cell Physiol

Author:

Botti Gerardo¹,Giordano Antonio²³^ORCID,Feroce Florinda⁴,Chiara Anna Rosaria⁴,Cantile Monica⁴^ORCID

Affiliation:

1. Scientific Direction Istituto Nazionale Tumori‐Irccs‐Fondazione G.Pascale Naples Italy

2. Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology College of Science and Technology Temple University Philadelphia Pennsylvania

3. Department of Medicine Surgery and Neuroscience University of Siena Siena Italy

4. Pathology Unit Istituto Nazionale Tumori‐Irccs‐Fondazione G.Pascale Naples Italy

Funder

Italian Ministry of Health

Publisher

Wiley

Subject

Cell Biology,Clinical Biochemistry,Physiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/jcp.28744

Reference84 articles.

1. HUR protects NONO from degradation by mir320, which is induced by p53 upon UV irradiation

2. Cross‐species identification of a plasma microRNA signature for detection, therapeutic monitoring, and prognosis in osteosarcoma

3. Circulating long non‐coding RNAs: Could they be a useful tool for cancer therapy monitoring?;Botti G.;Expert Review of Anticancer Therapy,2018

4. Serum miR-195 is a diagnostic and prognostic marker for osteosarcoma

5. The lncRNA HNF1A-AS1 is a negative prognostic factor and promotes tumorigenesis in osteosarcoma

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intelligent structure prediction and visualization analysis of non-coding RNA in osteosarcoma research;Frontiers in Oncology;2024-03-12

2. MiR-4270 acts as a tumor suppressor by directly targeting Bcl-xL in human osteosarcoma cells;Frontiers in Oncology;2023-08-31

3. miRNA, lncRNA and circRNA: targeted molecules with therapeutic promises in Mycoplasma pneumoniae infection;Archives of Microbiology;2023-07-21

4. CDKN2B-AS1 as a novel therapeutic target in cancer: Mechanism and clinical perspective;Biochemical Pharmacology;2023-07

5. Knockdown of LncRNA DICER1-AS1 arrests the cell cycle, inhibits cell proliferation, and induces cell apoptosis by regulating CDC5L nuclear transfer in osteosarcoma;Connective Tissue Research;2023-06-13